Evaluation of the feasibility of artificial intelligence models as patient information advisors for human papillomavirus vaccines.
| Title: | Evaluation of the feasibility of artificial intelligence models as patient information advisors for human papillomavirus vaccines. |
|---|---|
| Authors: | Kaya A; Düzce University, Faculty of Medicine, Department of Family Medicine - Düzce, Turkey.; Kücükdag HN; Düzce University, Faculty of Medicine, Department of Family Medicine - Düzce, Turkey.; Keyif B; Düzce University, Faculty of Medicine, Department of Obstetrics and Gynecology - Düzce, Turkey. |
| Source: | Revista da Associacao Medica Brasileira (1992) [Rev Assoc Med Bras (1992)] 2025 Dec 08; Vol. 71 (11), pp. e20250809. Date of Electronic Publication: 2025 Dec 08 (Print Publication: 2025). |
| Publication Type: | Journal Article; Evaluation Study |
| Language: | English |
| Journal Info: | Publisher: Associação Médica Brasileira Country of Publication: Brazil NLM ID: 9308586 Publication Model: eCollection Cited Medium: Internet ISSN: 1806-9282 (Electronic) Linking ISSN: 01044230 NLM ISO Abbreviation: Rev Assoc Med Bras (1992) Subsets: MEDLINE |
| Imprint Name(s): | Original Publication: São Paulo : Associação Médica Brasileira |
| MeSH Terms: | Papillomavirus Infections*/prevention & control ; Patient Education as Topic*/methods ; Papillomavirus Vaccines* ; Artificial Intelligence*; Humans ; Reproducibility of Results ; Feasibility Studies ; Comprehension ; Surveys and Questionnaires |
| Abstract: | Objective: Artificial intelligence chatbots are increasingly used to disseminate health information. The aim of this study was to evaluate the accuracy, reliability, quality, and readability of responses generated by four artificial intelligence chatbots regarding human papillomavirus vaccination.; Methods: Frequently asked questions about human papillomavirus vaccination were identified using a Google search tool, and these questions were posed to the ChatGPT-3.5, Gemini, Copilot artificial intelligence, and ChatGPT-4 models. Responses were assessed for accuracy (five-point Likert scale), reliability (modified DISCERN scale), quality (Global Quality Scale), and readability (Flesch Reading Ease Score). Interobserver agreement was evaluated by the intraclass correlation coefficient. The results were evaluated at a significance level of p |
| References: | New Microbiol. 2017 Apr;40(2):80-85. (PMID: 28368072); Front Digit Health. 2023 Apr 12;5:1161098. (PMID: 37122812); J Infect. 2013 Mar;66(3):207-17. (PMID: 23103285); Front Artif Intell. 2023 Oct 31;6:1237704. (PMID: 38028668); Vaccine. 2009 Dec 9;27(52):7236-7. (PMID: 19450645); BMC Med Educ. 2024 Oct 7;24(1):1096. (PMID: 39375721); Am J Orthod Dentofacial Orthop. 2024 May;165(5):546-555. (PMID: 38300168); J Epidemiol Community Health. 1999 Feb;53(2):105-11. (PMID: 10396471); PLoS One. 2020 Mar 19;15(3):e0230058. (PMID: 32191725); J Family Med Prim Care. 2025 Apr;14(4):1212-1217. (PMID: 40396077); J Med Syst. 2024 Feb 17;48(1):22. (PMID: 38366043); Health Informatics J. 2025 Jan-Mar;31(1):14604582251315587. (PMID: 39828887); JMIR Cancer. 2025 Apr 16;11:e63677. (PMID: 40239208); Rev Obstet Gynecol. 2008 Winter;1(1):2-10. (PMID: 18701931); Vaccine. 2006 Aug 31;24 Suppl 3:S3/210-8. (PMID: 16950009); BMC Med Inform Decis Mak. 2024 Dec 24;24(1):404. (PMID: 39719573); JMIR Med Educ. 2023 Nov 1;9:e51421. (PMID: 37910155); Eur J Orthod. 2024 Apr 13;:. (PMID: 38613510); Angle Orthod. 2020 May 1;90(3):419-424. (PMID: 33378436); PLoS One. 2020 Nov 12;15(11):e0241674. (PMID: 33180790); Patient Educ Couns. 2006 May;61(2):173-90. (PMID: 16122896); BMC Med Inform Decis Mak. 2024 Jul 29;24(1):211. (PMID: 39075513) |
| Substance Nomenclature: | 0 (Papillomavirus Vaccines) |
| Entry Date(s): | Date Created: 20251210 Date Completed: 20251210 Latest Revision: 20251212 |
| Update Code: | 20260130 |
| PubMed Central ID: | PMC12695122 |
| DOI: | 10.1590/1806-9282.20250809 |
| PMID: | 41370489 |
| Database: | MEDLINE |
Journal Article; Evaluation Study